A Multimodal Nanoparticle for Preoperative Magnetic Resonance Imaging and Intraoperative Optical Brain Tumor Delineation

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8122-8125

  Kircher, Moritz F ^a   Mahmood, Umar ^a   King, Raymond S ^a   Weissleder, Ralph ^a   Josephson, Lee ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CY5 5 CROSS LINKED IRON OXIDE NANOPARTICLE; GREEN FLUORESCENT PROTEIN; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; DRUG DISTRIBUTION; DRUG METABOLISM; GLIOSARCOMA; IMAGING SYSTEM; INTRAOPERATIVE PERIOD; MAGNETISM; MICROGLIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; TREATMENT PLANNING;

ANIMALS; BRAIN NEOPLASMS; CARBOCYANINES; FERRIC COMPOUNDS; FLUORESCENT DYES; GLIOSARCOMA; MAGNETIC RESONANCE IMAGING; NANOTECHNOLOGY; PARTICLE SIZE; RATS; RATS, INBRED F344; SUBCELLULAR FRACTIONS;

EID: 0347626110     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lin, W. C., Toms, S. A., Johnson, M., Jansen, E. D., and Mahadevan-Jansen, A. In vivo brain tumor demarcation using optical spectroscopy. Photochem. Photobiol., 73: 396-402, 2001.
2. Eggert, H. R., and Blazek, V. Optical properties of human brain tissue, meninges, and brain tumors in the spectral range of 200 to 900 nm. Neurosurgery, 21: 459-464, 1987.
3. Stummer, W., Stocker, S., Wagner, S., Stepp, H., Fritsch, C., Goetz, C., Goetz, A. E., Kiefmann, R., and Reulen, H. J. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery, 42: 518-525; discussion 525-516, 1998.
4. Schulder, M., and Carmel, P. W. Intraoperative magnetic resonance imaging: impact on brain tumor surgery. Cancer Control, 10: 115-124, 2003.
5. Ludemann, L., Hamm, B., and Zimmer, C. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. Magn. Reson. Imaging, 18: 1201-1214, 2000.
6. Knauth, M., Wirtz, C. R., Aras, N., and Sartor, K. Low-field interventional MRI in neurosurgery: finding the right dose of contrast medium. Neuroradiology, 43: 254-258, 2001.
7. Knauth, M., Aras, N., Wirtz, C. R., Dorfler, A., Engelhorn, T., and Sarlor, K. Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am. J. Neuroradiol., 20: 1547-1553, 1999.
8. Fleige, G., Nolte, C., Synowitz, M., Seeberger, F., Kettenmann, H., and Zimmer, C. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia, 3: 489-499, 2001.
9. Enochs, W. S., Harsh, G., Hochberg, F., and Weissleder, R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging, 9: 228-232, 1999.
10. Knauth, M., Egelhof, T., Roth, S. U., Wirtz, C. R., and Sartor, K. Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. AJNR Am J Neuroradiol., 22: 99-102, 2001.
11. Josephson, L., Tung, C. H., Moore, A., and Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem., 10: 186-191, 1999.
12. Josephson, L., Perez, J. M., and Weissleder, R. Magnetic nanosensors for the detection of oligonucleotide sequences. Angew. Chem. Int. Ed. Engl., 40: 3204-3206, 2001.
13. Shen, T., Weissleder, R., Papisov, M., Bogdanov, A., Jr., and Brady, T. J. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med., 29: 599-604, 1993.
14. Moore, A., Marecos, E., Simonova, M., Weissleder, R., and Bogdanov, A., Jr. Novel gliosarcoma cell line expressing green fluorescent protein: a model for quantitative assessment of angiogenesis. Microvasc. Res., 56: 145-153, 1998.
15. Mahmood, U., Tung, C. H., Tang, Y., and Weissleder, R. Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. Radiology, 224: 446-451, 2002.
16. Rogers, J., Lewis, J., and Josephson, L. Use of AM1-227 as an oral MR contrast agent. Magn. Reson. Med., 12: 631-639, 1994.
17. Weissleder, R., Stark, D. D., Engelstad, B. L., Bacon, B. R., Compton, C. C., White, D. L., Jacobs, P., and Lewis, J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J. Roentgenol., 152: 167-173, 1989.
18. Ntziachristos, V., Yodh, A. G., Schnall, M., and Chance, B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl. Acad. Sci. USA, 97: 2767-2772, 2000.
19. Thiessen, J. J., Rappaport, P. L., and Eppel, J. G. Indocyanine green pharmacokinetics in the rabbit. Can. J. Physiol. Pharmacol., 62: 1078-1085, 1984.
20. Weissleder, R. and Ntziachristos, V. Shedding light onto live molecular targets. Nat. Med., 9: 123-128, 2003.